Adaptimmune Therapeutics
ADAP
#9240
Rank
HK$0.56 B
Marketcap
HK$2.15
Share price
4.45%
Change (1 day)
-76.13%
Change (1 year)

EPS for Adaptimmune Therapeutics (ADAP)

EPS in 2023 (TTM): -HK$4.18

According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$4.14. In 2022 the company made an earnings per share (EPS) of -HK$7.91 a decrease over its 2021 EPS that were of -HK$7.91.

EPS history for Adaptimmune Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$4.18-47.14%
2022-HK$7.91-0%
2021-HK$7.916.25%
2020-HK$7.45-27.27%
2019-HK$10.2429.41%
2018-HK$7.9120.09%
2017-HK$6.59-16.73%
2016-HK$7.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$55.77 1,247.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$7.29 76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$30.56 638.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$2.20-153.08%๐Ÿ‡บ๐Ÿ‡ธ USA